MORGAN STANLEY - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$108,113
-27.4%
291,411
-2.0%
0.00%
Q3 2022$149,000
-29.7%
297,480
-17.9%
0.00%
Q2 2022$212,000
-2.3%
362,553
+19.1%
0.00%
Q1 2022$217,000
-58.4%
304,450
-22.9%
0.00%
Q4 2021$522,000
+52.6%
394,894
+165.4%
0.00%
Q3 2021$342,000
-8.8%
148,798
+74.2%
0.00%
Q2 2021$375,000
+184.1%
85,431
+368.7%
0.00%
Q1 2021$132,000
-94.7%
18,226
-96.8%
0.00%
Q4 2020$2,478,000
+30.7%
573,414
+24.3%
0.00%
Q3 2020$1,896,000
-48.7%
461,325
-25.1%
0.00%
-100.0%
Q2 2020$3,696,000
+7442.9%
616,105
+9299.0%
0.00%
Q1 2020$49,000
-39.5%
6,555
+11.8%
0.00%
Q4 2019$81,000
-26.4%
5,865
-36.6%
0.00%
Q3 2019$110,000
+5400.0%
9,250
+6066.7%
0.00%
Q2 2019$2,000
-93.9%
150
-91.7%
0.00%
Q1 2019$33,000
-75.7%
1,808
-79.0%
0.00%
Q4 2018$136,0008,6250.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 2,931,185$12,047,0004.29%
RA Capital Management 12,315,213$50,616,0000.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$28,562,0000.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 620,233$2,549,0000.35%
Casdin Capital, LLC 1,870,000$7,686,0000.34%
Vivo Capital, LLC 1,325,736$5,449,0000.32%
Bleichroeder LP 250,000$1,028,0000.18%
Virtus ETF Advisers LLC 40,292$166,0000.09%
Forefront Analytics, LLC 30,369$123,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 411,977$1,693,0000.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders